Based on it’s experience in entering the pharmaceutical industry by introducing it’s cough syrup a short time ago, Value Drugs expects to be equally successful broadening it’s product mix to include a stomach-relief medication and expanding the production capacity for it’s cough syrup product to achieve greater market share.  

According to market conditions and company forecasts, the company projects the growth of it’s stomach-relief medication to continue at a steady pace to the point where it expects gross sales to exceed $2.8 million by the end of next year.  Similarly, the introduction of it’s new cough syrup product is expected to bring in initial sales of $2.3 million in it’s first year.  Even given the costs associated with it’s expansion and the company’s day-to-day operations, it anticipates turning a modest profit in the coming year.